C
Cullinan Therapeutics, Inc. (CGEM)
NMS – Real Time Price. Currency in USD
16.15
+1.42 (9.64%)
At close: May 12, 2026, 4:00 PM EDT
16.14
-0.01 (-0.06%)
After-hours: May 12, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
16.15
+1.42 (9.64%)
At close: May 12, 2026, 4:00 PM EDT
16.14
-0.01 (-0.06%)
After-hours: May 12, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $75.1M significantly exceed its total debt $2.4M, ensuring strong financial flexibility
Total current assets $361.4M exceed Total current liabilities $35.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$46.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.28 | 6.05 | 10 | |
| Quick ratio | 10.28 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -93K | -310K | -306K | -311K | -314K |
| Operating Income | -132M | -191M | -197M | -242M | -240M |
| Net Income | 111M | -153M | -167M | -220M | -221M |
| EBITDA | -132M | -190M | -197M | -241M | -240M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 22.8 | 5.5 |
| Next quarter | N/A | -11.97 | 1.0 |
| Current year | N/A | 9.24 | 3.5 |
| Next year | 116.3 | 21.69 | 10 |
| Weighted average score | 5.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 2.07 | 2.6 | -20.78 | 4.5 |
| Y/Y | 999 | -2.38 | -1.34 | -4.07 | 3.3 |
| 3y average | 999 | -92.77 | -83.73 | -11.4 | 3.3 |
| 5y average | 779.2 | -7.05 | 15.52 | -54.85 | 5.3 |
| Weighted average score | 4.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |